Immunomodulators
A total of 141 FDA-approved immunomodulators were evaluated in the VigiBase analysis. Twenty immunomodulators remained significantly associated with atrial fibrillation over-reporting after adjustment and Bonferroni correction. The twenty…
1 sources - 4 claims
A total of 141 FDA-approved immunomodulators were evaluated in the VigiBase analysis. Twenty immunomodulators remained significantly associated with atrial fibrillation over-reporting after adjustment and Bonferroni correction. The twenty significant immunomodulators accounted for about half of all atrial fibrillation cases in the primary immunomodulator-reporting population. The study evaluated FDA-approved immunomodulators in ATC classes L03 and L04 with at least one VigiBase report.